{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:06:35Z","timestamp":1792026395236,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BK21FOUR program of the National Research Foundation of Korea","award":["the Ministry of Education (5120200513755)."],"award-info":[{"award-number":["the Ministry of Education (5120200513755)."]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["the Korea government from the Ministry of Science, ICT, and Future Planning (NRF-2019M3A9A8065574, and NRF-2022R1A2C2091831)"],"award-info":[{"award-number":["the Korea government from the Ministry of Science, ICT, and Future Planning (NRF-2019M3A9A8065574, and NRF-2022R1A2C2091831)"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36645-5","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:06:46Z","timestamp":1769126806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epigenetic suppression of synovial inflammation and osteoclast differentiation in rheumatoid arthritis by I-BET762"],"prefix":"10.1038","volume":"16","author":[{"given":"Ra Ham","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Un","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"5","key":"36645_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/art.39563","volume":"68","author":"Y Araki","year":"2016","unstructured":"Araki, Y. et al. Histone methylation and STAT-3 differentially regulate interleukin-6-induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol. 68(5), 1111\u20131123 (2016).","journal-title":"Arthritis Rheumatol."},{"issue":"7327","key":"36645_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"Nicodeme, E. et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327), 1119\u20131123 (2010).","journal-title":"Nature"},{"issue":"6924","key":"36645_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924), 744\u2013748 (2003).","journal-title":"Nature"},{"issue":"7","key":"36645_CR4","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/molecules28073043","volume":"28","author":"KKW To","year":"2023","unstructured":"To, K. K. W., Xing, E., Larue, R. C. & Li, P. K. BET bromodomain inhibitors: novel design strategies and therapeutic applications. Molecules 28(7), 3043 (2023).","journal-title":"Molecules"},{"issue":"23","key":"36645_CR5","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1111\/bph.14486","volume":"175","author":"LJ Kang","year":"2018","unstructured":"Kang, L. J. et al. 3\u2032-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. Br. J. Pharmacol. 175(23), 4295\u20134309 (2018).","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"36645_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2217\/epi-2016-0151","volume":"9","author":"KM Doody","year":"2017","unstructured":"Doody, K. M., Bottini, N. & Firestein, G. S. Epigenetic alterations in rheumatoid arthritis fibroblast-like synoviocytes. Epigenomics 9(4), 479\u2013492 (2017).","journal-title":"Epigenomics"},{"issue":"9","key":"36645_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1136\/annrheumdis-2018-214783","volume":"78","author":"C Loh","year":"2019","unstructured":"Loh, C. et al. TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis. Ann. Rheum. Dis. 78(9), 1205\u20131214 (2019).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"36645_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/art.38871","volume":"67","author":"C Sohn","year":"2015","unstructured":"Sohn, C. et al. Prolonged tumor necrosis factor alpha primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol. 67(1), 86\u201395 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"36645_CR9","doi-asserted-by":"publisher","first-page":"172492","DOI":"10.1016\/j.ejphar.2019.172492","volume":"858","author":"T Inoue","year":"2019","unstructured":"Inoue, T. et al. Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance. Eur. J. Pharmacol. 858, 172492 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"36645_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fgene.2019.01104","volume":"10","author":"JS Ibanez-Cabellos","year":"2019","unstructured":"Ibanez-Cabellos, J. S., Seco-Cervera, M., Osca-Verdegal, R., Pallardo, F. V. & Garcia-Gimenez, J. L. Epigenetic regulation in the pathogenesis of sjogren syndrome and rheumatoid arthritis. Front. Genet. 10, 1104 (2019).","journal-title":"Front. Genet."},{"issue":"12","key":"36645_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd.2016.185","volume":"15","author":"DF Tough","year":"2016","unstructured":"Tough, D. F., Tak, P. P., Tarakhovsky, A. & Prinjha, R. K. Epigenetic drug discovery: breaking through the immune barrier. Nat. Rev. Drug Discov. 15(12), 835\u2013853 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"36645_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5312\/wjo.v4.i4.178","volume":"4","author":"T Yoneda","year":"2013","unstructured":"Yoneda, T., Tanaka, S. & Hata, K. Role of RANKL\/RANK in primary and secondary breast cancer. World J. Orthop. 4(4), 178\u2013185 (2013).","journal-title":"World J. Orthop."},{"issue":"21","key":"36645_CR13","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1016\/j.febslet.2006.08.025","volume":"580","author":"SF Krens","year":"2006","unstructured":"Krens, S. F., Spaink, H. P. & Snaar-Jagalska, B. E. Functions of the MAPK family in vertebrate-development. FEBS Lett. 580(21), 4984\u20134990 (2006).","journal-title":"FEBS Lett."},{"issue":"5","key":"36645_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.autrev.2012.10.019","volume":"12","author":"A Mavropoulos","year":"2013","unstructured":"Mavropoulos, A. et al. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun. Rev. 12(5), 580\u2013590 (2013).","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"36645_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/annrheumdis-2014-205809","volume":"75","author":"K Klein","year":"2016","unstructured":"Klein, K. et al. The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts. Ann. Rheum. Dis. 75(2), 422\u2013429 (2016).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"36645_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/gut.52.1.144","volume":"52","author":"DW Hommes","year":"2003","unstructured":"Hommes, D. W., Peppelenbosch, M. P. & van Deventer, S. J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52(1), 144\u2013151 (2003).","journal-title":"Gut"},{"issue":"2","key":"36645_CR17","doi-asserted-by":"publisher","first-page":"e000744","DOI":"10.1136\/rmdopen-2018-000744","volume":"4","author":"K Klein","year":"2018","unstructured":"Klein, K. Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases. RMD Open 4(2), e000744 (2018).","journal-title":"RMD Open"},{"issue":"2","key":"36645_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1086\/598822","volume":"84","author":"E Jablonka","year":"2009","unstructured":"Jablonka, E. & Raz, G. Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q. Rev. Biol. 84(2), 131\u2013176 (2009).","journal-title":"Q. Rev. Biol."},{"issue":"1","key":"36645_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos, P. et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1), 214\u2013231 (2012).","journal-title":"Cell"},{"issue":"6","key":"36645_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16(6), 316\u2013333 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"36645_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-020-00384-4","volume":"6","author":"N Wang","year":"2021","unstructured":"Wang, N., Wu, R., Tang, D. & Kang, R. The BET family in immunity and disease. Signal Transduct. Target Ther. 6(1), 23 (2021).","journal-title":"Signal Transduct. Target Ther."},{"issue":"7327","key":"36645_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468(7327), 1067\u20131073 (2010).","journal-title":"Nature"},{"issue":"6","key":"36645_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1124\/mol.117.110379","volume":"92","author":"R Jahagirdar","year":"2017","unstructured":"Jahagirdar, R. et al. RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease. Mol. Pharmacol. 92(6), 694\u2013706 (2017).","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"36645_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000150028","volume":"29","author":"M Lehtinen","year":"1988","unstructured":"Lehtinen, M. et al. Phospholipase-A2 activity is copurified together with herpes-simplex virus-specified fc-receptor proteins. Intervirology 29(1), 50\u201356 (1988).","journal-title":"Intervirology"},{"key":"36645_CR25","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1038\/ncomms14852","volume":"8","author":"M Frank-Bertoncelj","year":"2017","unstructured":"Frank-Bertoncelj, M. et al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat. Commun. 8, 14852 (2017).","journal-title":"Nat. Commun."},{"key":"36645_CR26","doi-asserted-by":"publisher","first-page":"172492","DOI":"10.1016\/j.ejphar.2019.172492","volume":"858","author":"T Inoue","year":"2019","unstructured":"Inoue, T. et al. Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance. Eur. J. Pharmacol. 858, 172492 (2019).","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"36645_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jbmr.4215","volume":"36","author":"X Zhao","year":"2021","unstructured":"Zhao, X., Lin, S., Li, H., Si, S. & Wang, Z. Myeloperoxidase controls bone turnover by suppressing osteoclast differentiation through modulating reactive oxygen species level. J. Bone Miner. Res. 36(3), 591\u2013603 (2021).","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"36645_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14348\/molcells.2017.0225","volume":"40","author":"JH Park","year":"2017","unstructured":"Park, J. H., Lee, N. K. & Lee, S. Y. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol. Cells 40(10), 706\u2013713 (2017).","journal-title":"Mol. Cells"},{"key":"36645_CR29","doi-asserted-by":"publisher","first-page":"115471","DOI":"10.1016\/j.bone.2020.115471","volume":"138","author":"D Kurotaki","year":"2020","unstructured":"Kurotaki, D., Yoshida, H. & Tamura, T. Epigenetic and transcriptional regulation of osteoclast differentiation. Bone 138, 115471 (2020).","journal-title":"Bone"},{"issue":"3","key":"36645_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/ijms23031500","volume":"23","author":"L Oton-Gonzalez","year":"2022","unstructured":"Oton-Gonzalez, L. et al. Genetics and epigenetics of bone remodeling and metabolic bone diseases. Int. J. Mol. Sci. 23(3), 1500 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"36645_CR31","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.3390\/ijms21165685","volume":"21","author":"J Kodama","year":"2020","unstructured":"Kodama, J. & Kaito, T. Osteoclast multinucleation: review of current literature. Int. J. Mol. Sci. 21(16), 5685 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"36645_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41423-022-00959-x","volume":"20","author":"S Bae","year":"2023","unstructured":"Bae, S. et al. RANKL-responsive epigenetic mechanism reprograms macrophages into bone-resorbing osteoclasts. Cell Mol. Immunol. 20(1), 94\u2013109 (2023).","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"36645_CR33","doi-asserted-by":"publisher","first-page":"pkz093","DOI":"10.1093\/jncics\/pkz093","volume":"4","author":"SA Piha-Paul","year":"2020","unstructured":"Piha-Paul, S. A. et al. Phase 1 study of molibresib (GSK525762), a bromodomain and extra-terminal domain protein inhibitor, in NUT carcinoma and other solid tumors. JNCI Cancer Spectr. 4(2), pkz093 (2020).","journal-title":"JNCI Cancer Spectr."},{"issue":"1","key":"36645_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41392-024-01826-z","volume":"9","author":"N Yin","year":"2024","unstructured":"Yin, N. et al. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities. Signal. Transduct. Target Ther. 9(1), 126 (2024).","journal-title":"Signal. Transduct. Target Ther."},{"issue":"23","key":"36645_CR35","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1111\/bph.14486","volume":"175","author":"LJ Kang","year":"2018","unstructured":"Kang, L. J. et al. 3\u2032-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. Brit. J. Pharmacol. 175(23), 4295\u20134309 (2018).","journal-title":"Brit. J. Pharmacol."},{"issue":"7987","key":"36645_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623(7987), 616\u2013624 (2023).","journal-title":"Nature"},{"issue":"3","key":"36645_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cell.2010.03.030","volume":"141","author":"PB Rahl","year":"2010","unstructured":"Rahl, P. B. et al. c-Myc regulates transcriptional pause release. Cell 141(3), 432\u2013445 (2010).","journal-title":"Cell"},{"issue":"4","key":"36645_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/art.42378","volume":"75","author":"J Friscic","year":"2023","unstructured":"Friscic, J. et al. Reset of inflammatory priming of joint tissue and reduction of the severity of arthritis flares by bromodomain inhibition. Arthritis Rheumatol. 75(4), 517\u2013532 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"36645_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","volume":"223","author":"EH Noss","year":"2008","unstructured":"Noss, E. H. & Brenner, M. B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223, 252\u2013270 (2008).","journal-title":"Immunol. Rev."},{"issue":"1","key":"36645_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-018-1631-y","volume":"20","author":"LT Donlin","year":"2018","unstructured":"Donlin, L. T. et al. Methods for high-dimensional analysis of cells dissociated from cryopreserved synovial tissue. Arthritis Res. Ther. 20(1), 139 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"36645_CR41","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-kappaB signaling in inflammation. Signal Transduct. Target Ther. 2, 17023 (2017).","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"36645_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-myc. Cell 146(6), 903\u2013916 (2011).","journal-title":"Cell"},{"issue":"14","key":"36645_CR43","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1128\/MCB.00586-07","volume":"27","author":"L Amir-Zilberstein","year":"2007","unstructured":"Amir-Zilberstein, L. et al. Differential regulation of NF-kappa B by elongation factors is determined by core promoter type. Mol. Cell Biol. 27(14), 5246\u20135259 (2007).","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"36645_CR44","doi-asserted-by":"publisher","first-page":"17112","DOI":"10.1038\/s41598-023-44412-z","volume":"13","author":"M Krosel","year":"2023","unstructured":"Krosel, M. et al. The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels. Sci. Rep. 13(1), 17112 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"36645_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2009.171","volume":"5","author":"SE Sweeney","year":"2009","unstructured":"Sweeney, S. E. The as-yet unfulfilled promise of p38 MAPK inhibitors. Nat. Rev. Rheumatol. 5(9), 475\u2013477 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"36645_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","volume":"11","author":"LN Samimi","year":"2020","unstructured":"Samimi, L. N. et al. NF-kappa B signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Autoimmun. Highlights 11(1), 11 (2020).","journal-title":"Autoimmun. Highlights"},{"issue":"1","key":"36645_CR47","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41467-023-37116-5","volume":"14","author":"J Du","year":"2023","unstructured":"Du, J. et al. BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism. Nat. Commun. 14(1), 1413 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"36645_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bcp.2005.04.047","volume":"70","author":"J Hu","year":"2005","unstructured":"Hu, J., Van den Steen, P. E., Dillen, C. & Opdenakker, G. Targeting neutrophil collagenase\/matrix metalloproteinase-8 and gelatinase B\/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem. Pharmacol. 70(4), 535\u2013544 (2005).","journal-title":"Biochem. Pharmacol."},{"issue":"6489","key":"36645_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.aaz8455","volume":"368","author":"O Gilan","year":"2020","unstructured":"Gilan, O. et al. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation. Science 368(6489), 387\u2013394 (2020).","journal-title":"Science"},{"issue":"1","key":"36645_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello, M. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. R. 75(1), 50\u201383 (2011).","journal-title":"Microbiol. Mol. Biol. R."},{"issue":"520","key":"36645_CR51","doi-asserted-by":"publisher","first-page":"eaal1601","DOI":"10.1126\/scisignal.aal1601","volume":"11","author":"DS Jones","year":"2018","unstructured":"Jones, D. S., Jenney, A. P., Joughin, B. A., Sorger, P. K. & Lauffenburger, D. A. Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition. Sci. Signal. 11(520), eaal1601 (2018).","journal-title":"Sci. Signal."},{"issue":"529","key":"36645_CR52","doi-asserted-by":"publisher","first-page":"eaaw6143","DOI":"10.1126\/scitranslmed.aaw6143","volume":"12","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases. Sci. Transl. Med. 12(529), eaaw6143 (2020).","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"36645_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-024-01274-w","volume":"31","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. The histone methyltransferase ASH1L protects against bone loss by inhibiting osteoclastogenesis. Cell Death Differ. 31(5), 605\u2013617 (2024).","journal-title":"Cell Death Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36645-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36645-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36645-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T22:02:50Z","timestamp":1770933770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36645-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36645-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6042"}}